{"slideshow_credits": null, "snippet": "The alliance seeks to build on the results of an experimental treatment that trains a person\u2019s immune system to kill cancer cells.", "abstract": "Drugmaker Novartis and University of Pennsylvania announce research and licensing agreement that seeks to build on the promising results of an experimental treatment that trains a person's immune system to kill cancer cells.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/08/06/business/novartis-and-penn-unite-on-anticancer-approach.html", "lead_paragraph": "The alliance seeks to build on the results of an experimental treatment that trains a person\u2019s immune system to kill cancer cells.", "headline": {"seo": "Novartis and Penn Unite On Anticancer Approach", "main": "Novartis and Penn Unite on New Anticancer Path", "print_headline": "Novartis and Penn Unite On New Anticancer Path"}, "_id": "515d9dd0cf28d0219d000896", "word_count": "419", "multimedia": [], "pub_date": "2012-08-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "University of Pennsylvania", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Novartis AG", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Colleges and Universities", "name": "subject", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}